Nitroxide Antioxidant Modulation of HSP90 Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively address irregular gene expression levels, particularly overexpression of heat shock proteins like HSP90, which contribute to various diseases and conditions, including cancer, autoimmune diseases, and aging, by not providing sufficient means to decrease or increase expression levels as needed.
Innovation Solution
Administering an effective amount of a nitroxide antioxidant, such as 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, to human subjects with increased HSP90 expression levels, specifically targeting and decreasing or increasing the expression levels in tissues like skin, adipose, and neuronal tissues, depending on the condition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If heat shock proteins like HSP90 are overexpressed to protect cells from stress, then cell survival and stress resistance are improved, but disease development and progression are worsened
Solution Approach 1:
The patent uses nitroxide antioxidants to modulate the expression levels of heat shock protein genes, specifically changing the parameter of gene expression from overexpressed to normalized levels. This resolves the contradiction by reducing HSP90 expression in disease states while maintaining adequate protection in normal physiological conditions
Solution Approach 2:
The patent extracts and targets the specific harmful overexpression of heat shock proteins like HSP90 using nitroxide antioxidants, separating the harmful overexpression from the necessary protective function. The nitroxides selectively reduce pathological HSP90 levels without completely eliminating the protein's protective roles
2Stability of the object's composition
If natural control of gene expression is allowed to operate, then normal physiological function is maintained, but disease progression is worsened when control fails
Solution Approach 1:
The patent introduces nitroxide antioxidants as intermediary substances that mediate between the failed natural gene expression control system and the overexpressed heat shock proteins. The nitroxides act as external regulators that restore proper gene expression levels when endogenous control mechanisms fail
Solution Approach 2:
The patent changes the gene expression parameter from dysregulated (natural control failure) to regulated (therapeutically controlled) by administering nitroxides that specifically target and normalize heat shock protein expression levels in diseased states
3Reliability
If heat shock proteins are overexpressed to provide cellular protection, then stress resistance is improved, but cancer development and treatment resistance are worsened
Solution Approach 1:
The patent changes the expression parameter of HSP90 from elevated (providing cancer protection) to normalized (sensitive to treatment) levels using nitroxide antioxidants. This resolves the contradiction by reducing the protective buffer that cancer cells use to resist chemotherapy while maintaining cell viability
Solution Approach 2:
The patent converts the harmful overexpression of HSP90 that protects cancer cells into a therapeutic target. By using nitroxide antioxidants to reduce HSP90 levels, the treatment exploits the very mechanism (heat shock response) that cancer cells rely on for protection, turning it against them to increase treatment sensitivity
Data Source
AI summary
Some embodiments disclosed herein include a method for decreasing an expression level of a gene. The methods can include identifying a human subject having an increased expression level of hsp90; and administering to the human subject an effective amount of a nitroxide antioxidant, whereby expression level of the gene is decreased.